Cargando…

Narrative review of pembrolizumab for the treatment of esophageal cancer: evidence and outlook

OBJECTIVE: Based on the current evidence, review the efficacy and safety profile of pembrolizumab, along with its shortcomings, in an effort to define future research directions. BACKGROUND: The survival outcome of esophageal cancer (EC) is poor, especially in patients with advanced stage. Palliativ...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jin, Zixian, Shen, Jianfei, Wang, Chunguo, Chen, Dong, Zhang, Bo, Zhang, Jian, Ajani, Jaffer A., Bennouna, Jaafar, Chao, Joseph, Yoon, Harry H., Zhu, Hongyu, Ruan, Yuhang, Zhu, Chengchu, Xu, Anyi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2021
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8350624/ https://www.ncbi.nlm.nih.gov/pubmed/34430630 http://dx.doi.org/10.21037/atm-21-2804

Ejemplares similares

Neoadjuvant immunotherapy with resectable non-small cell lung cancer: recent advances and future challenges
por: Ren, Sijia, et al.
Publicado: (2020)

Efficacy and safety of vinorelbine and cisplatin regimen of different doses and intensities for neoadjuvant chemotherapy in patients with locally advanced esophageal carcinoma
por: Jin, Ke, et al.
Publicado: (2021)

The role of ferroptosis in esophageal cancer
por: Wang, Zimin, et al.
Publicado: (2022)

PD‐1/PD‐L1 based immunochemotherapy versus chemotherapy alone for advanced esophageal squamous cell carcinoma: A meta‐analysis focus on PD‐L1 expression level
por: Jin, Zixian, et al.
Publicado: (2023)

A single-arm, multicenter, phase II clinical study of tislelizumab plus albumin-bound paclitaxel/cisplatin as neoadjuvant therapy for borderline resectable esophageal squamous cell carcinoma
por: Li, Xiaodong, et al.
Publicado: (2022)

A narrative review of primary research endpoints of neoadjuvant therapy for lung cancer: past, present and future
por: Ren, Sijia, et al.
Publicado: (2021)

Silencing of A-kinase anchor protein 4 inhibits the metastasis and growth of non-small cell lung cancer
por: Zhang, Bo, et al.
Publicado: (2022)

KEYNOTE-975 study design: a Phase III study of definitive chemoradiotherapy plus pembrolizumab in patients with esophageal carcinoma
por: Shah, Manish A, et al.
Publicado: (2021)

Prognostic factors for survival in esophageal squamous cell carcinoma (ESCC) patients with a complete regression of the primary tumor (ypT0) after neoadjuvant chemoradiotherapy (NCRT) followed by surgery
por: Kong, Min, et al.
Publicado: (2020)

Endoscopic management of esophageal cancer
por: Ahmed, Osman, et al.
Publicado: (2019)

Minimally invasive esophagectomy for esophageal cancer in the People’s Republic of China: an overview
por: Zhu, Chengchu, et al.
Publicado: (2013)

Efficacy and Safety of Neoadjuvant Targeted Therapy vs. Neoadjuvant Chemotherapy for Stage IIIA EGFR-Mutant Non-small Cell Lung Cancer: A Systematic Review and Meta-Analysis
por: Chen, Dong, et al.
Publicado: (2021)

Is endoscopic ultrasound examination necessary in the management of esophageal cancer?
por: DaVee, Tomas, et al.
Publicado: (2017)

Recent advances in preoperative management of esophageal adenocarcinoma
por: Harada, Kazuto, et al.
Publicado: (2017)

Editorial: Surgical Selection of Sublobar Resection and Scope of Lymph Node Dissection for Early-Stage Lung Cancer
por: Sun, Jiajing, et al.
Publicado: (2022)

Efficacy and Benefit of Postoperative Chemotherapy in Micropapillray or Solid Predominant Pattern in Stage IB Lung Adenocarcinoma: A Systematic Review and Meta-Analysis
por: Xu, Congcong, et al.
Publicado: (2021)

An atrial septal aneurysm with an organized thrombus in an asymptomatic patient: A case report
por: Wang, Xinxin, et al.
Publicado: (2019)

Serum miR-331-3p predicts tumor recurrence in esophageal adenocarcinoma
por: Gu, Jianchun, et al.
Publicado: (2018)

Current treatments and outlook in adenocarcinoma of the esophagogastric junction: a narrative review
por: Cao, Fei, et al.
Publicado: (2022)

Modified McKeown Minimally Invasive Esophagectomy for Esophageal Cancer: A 5-Year Retrospective Study of 142 Patients in a Single Institution
por: Chen, Baofu, et al.
Publicado: (2013)

Pembrolizumab: A reliable second‐line treatment option for advanced esophageal cancer
por: Zheng, Li, et al.
Publicado: (2022)

Review and outlook of global energy use under the impact of COVID‐19
por: Zhang, Dongdong, et al.
Publicado: (2022)

Neurological Immune Related Adverse Events Associated with Nivolumab, Ipilimumab, and Pembrolizumab Therapy—Review of the Literature and Future Outlook
por: Möhn, Nora, et al.
Publicado: (2019)

Efficacy of Pembrolizumab in Advanced Melanoma: A Narrative Review
por: Rizzetto, Giulio, et al.
Publicado: (2023)

Effect of preoperative radiotherapy on the prognosis of patients with stage cTxN0M0 esophageal squamous cell carcinoma: propensity score matching analysis based on SEER database
por: Jin, Zixian, et al.
Publicado: (2023)

Left atrial concomitant surgical ablation for treatment of atrial fibrillation in cardiac surgery: A meta-analysis of randomized controlled trials
por: Wang, Xinxin, et al.
Publicado: (2018)

Outlook
por: Perkins, Donald Hill
Publicado: (1995)

Outlook
por: Glashow, Sheldon Lee
Publicado: (1991)

Outlook
por: Bodwin, G, et al.
Publicado: (2005)

Outlook
por: David Gross
Publicado: (2008)

Minimally invasive versus open esophagectomy after neoadjuvant therapy for esophageal cancer: a meta-analysis
por: Jin, Zixian, et al.
Publicado: (2023)

Can We Understand the Clinical Biology of Gastric Cancer and Exploit it? May be, but It is a Challenge!
por: Ajani, Jaffer A.
Publicado: (2007)

Efficacy and safety of immune checkpoint inhibitors versus chemotherapy in the second-line treatment of advanced esophageal squamous cell carcinoma: a meta-analysis and systematic review
por: Zhu, Kanghao, et al.
Publicado: (2023)

The role of ferroptosis in lung cancer
por: Wu, Sikai, et al.
Publicado: (2021)

Osimertinib for Front-Line Treatment of Locally Advanced or Metastatic EGFR-Mutant NSCLC Patients: Efficacy, Acquired Resistance and Perspectives for Subsequent Treatments
por: Denis, Marc G, et al.
Publicado: (2020)

Treatments for Non-Small-Cell Lung Cancer: The Multiple Options for Precision Medicine
por: Pons-Tostivint, Elvire, et al.
Publicado: (2022)

ABT-263 induces apoptosis and synergizes with chemotherapy by targeting stemness pathways in esophageal cancer
por: Chen, Qiongrong, et al.
Publicado: (2015)

Imaging of muscle and adipose tissue in the spine: A narrative review
por: Yang, Fan, et al.
Publicado: (2022)

Pathological mechanisms and therapeutic outlooks for arthrofibrosis
por: Usher, Kayley M., et al.
Publicado: (2019)

Outlook for 2012
por: Lamont, M
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_m7iqhhiads108o5vkms8aumn0t